The #global_c_reactive_protein_(CRP)_testing market is gaining strong traction as healthcare systems worldwide prioritize early detection of inflammatory conditions, infections, and cardiovascular diseases. CRP testing is a widely used diagnostic tool that measures the concentration of C-reactive protein in the blood, an essential biomarker of inflammation. Elevated CRP levels can signal underlying health issues ranging from bacterial infections to cardiovascular risk, making it a critical parameter in clinical practice.

Read more:
https://m2squareconsultancy.co....m/reports/c-reactive

C-reactive Protein (CRP) Testing Market Size, Share to 2033

The global CRP testing market is valued at USD 3.1B in 2025 and is projected to reach USD 5.8B by 2033, growing at a CAGR of 8.2%.